Merit Ebitda from 2010 to 2025

MMSI Stock  USD 101.68  0.40  0.39%   
Merit Medical's EBITDA is increasing with slightly volatile movements from year to year. EBITDA is estimated to finish at about 310.7 M this year. For the period between 2010 and 2025, Merit Medical, EBITDA quarterly trend regression had median of  45,225,000 and r-value of  0.88. View All Fundamentals
 
EBITDA  
First Reported
1989-03-31
Previous Quarter
73.8 M
Current Value
72.7 M
Quarterly Volatility
16.5 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Merit Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merit Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 120.5 M, Interest Expense of 32.8 M or Total Revenue of 1.4 B, as well as many indicators such as Price To Sales Ratio of 2.71, Dividend Yield of 0.0 or PTB Ratio of 3.62. Merit financial statements analysis is a perfect complement when working with Merit Medical Valuation or Volatility modules.
  
Check out the analysis of Merit Medical Correlation against competitors.

Latest Merit Medical's Ebitda Growth Pattern

Below is the plot of the Ebitda of Merit Medical Systems over the last few years. It is Merit Medical's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Merit Medical's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Merit Ebitda Regression Statistics

Arithmetic Mean102,209,388
Coefficient Of Variation98.66
Mean Deviation82,773,109
Median45,225,000
Standard Deviation100,837,750
Sample Variance10168.3T
Range311M
R-Value0.88
Mean Square Error2434.7T
R-Squared0.78
Slope18,664,019
Total Sum of Squares152523.8T

Merit Ebitda History

2025310.7 M
2024295.9 M
2023231.4 M
2022181.2 M
2021153.5 M
2020102.7 M
201938.6 M

About Merit Medical Financial Statements

Investors use fundamental indicators, such as Merit Medical's Ebitda, to determine how well the company is positioned to perform in the future. Although Merit Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
EBITDA295.9 M310.7 M

Currently Active Assets on Macroaxis

When determining whether Merit Medical Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Merit Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Merit Medical Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Merit Medical Systems Stock:
Check out the analysis of Merit Medical Correlation against competitors.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.04)
Earnings Share
2.03
Revenue Per Share
23.301
Quarterly Revenue Growth
0.094
Return On Assets
0.042
The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.